HLA System in Uremics with Cystic Diseases

  • C. C. Guida
  • M. D’Errico
  • F. Aucella
  • G. Ciavarella
  • G. C. Pompa
  • G. Di Giorgio
  • C. Stallone
Part of the Developments in Nephrology book series (DINE, volume 31)


We evaluated the prevalence of class I HLA antigens (A, B, C) in patients (pts) on regular dialysis treatment (RDT) affected with adult polycystic kidney diseases (APKD) (12 pts) and acquired renal cystic diseases (ARCD) (12 pts). 96 voluntary HLA-typed blood donors, randomly selected, were enrolled as healty controls. In APKD group we found the greater occurence of Bw22-Ag (p/0.004).


Polycystic Kidney Disease Cystic Disease Healty Control Autosomal Recessive Polycystic Kidney Disease Antigen Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Francke, U. and Pellegrino, M.A. Proc.natn.Acad.Sci. USA 74:1147–1151,1977.CrossRefGoogle Scholar
  2. 2.
    Lamm, L.U., Friedrich, U., Petersen, G.B., Jorgensen, J., Nielsen, J., Therkelsen, A.J. and Kissmeyer-Nielsen, F. Hum. Hered. 24: 243–284,1974.CrossRefGoogle Scholar
  3. 3.
    Someren, H. van, Westerveld, A., Hagemeijer, A., Mees, J.R., Khan, P.M. and Zaalberg, O.B. Proc.natn.Acad.Sci. USA 71:962–965, 1974.CrossRefGoogle Scholar
  4. 4.
    Ceppellini, R., Bonnard, G.D., Coppo, F., Miggiano, V.C., Pospisil, M., Curtoni, E.S. and Pellegrino, M. Transplant Proc. 3:58–70,1971.PubMedGoogle Scholar
  5. 5.
    Maschio, G., Lupo, A. and Valvo, E. Feder. Medica 38: 1032, 1985.Google Scholar
  6. 6.
    Dalgaard, O.Z. Acta Med. Scand. 328 (suppl. 1), 1957.Google Scholar
  7. 7.
    Dalgaard, O.Z. Can. Collège Méd.Hop. Paris 5:845, 1964.Google Scholar
  8. 8.
    Dausset, J., Hors, J. Transplant Rev. 22:44, 1975.PubMedGoogle Scholar
  9. 9.
    Milutinovic, J., Fialkow, P.J., Ruud, T.G. and al. Lancet i:1203, 1980.Google Scholar
  10. 10.
    Milutinovic, J., Agoda, L.J. Nephron 33:139, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Wing, A.J., Brunner, F.P., Gurland, H.J. and Jacobs C. in Proc.EDTA, Robson BHB and Hawkins, J.B. Eds, Pitman Medical 3, 1987.Google Scholar
  12. 12.
    Wing, A.J., Broyer, M., Brunner, F.P., and Selwood N.H. in Proc.EDTA, Davison A.M. and Guillou, P.J., Eds, Pitman Medical 2, 1983.Google Scholar
  13. 13.
    Chester, A.C., Geoly, K., Schreiner, G.E., and Preuss, H.G. Am.J. Physic 23:175, 1981.Google Scholar
  14. 14.
    Angelet, P., Sabria, M., Bartolone, J.,Camps, G., Olmos, A. and Piera, L. Rev.Clin.Espan. 160:315, 1981.PubMedGoogle Scholar
  15. 15.
    Kamaludin, T., Giudicelli, C.P., Lagrue, G. and Mas Bernard, A. Med.Armées 4:723, 1976.Google Scholar
  16. 16.
    Jacobsen, A., Birkelan, L.S. and Gabel, H. Scand.J.Urol.Nephrol. 54:71, 1980.Google Scholar
  17. 17.
    Steg, A. J.Urol.Nephrol. 81:287, 1975.Google Scholar
  18. 18.
    Mitcheson, H.D., William, G. and Castro, J.E. Br.Med.J. 1:1196, 1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Dyer, P.A., Watters, E.A. Klouda, P.T., Harris, R. and Mallick, N. P. Tissue Antigen 20:108, 1982.CrossRefGoogle Scholar
  20. 20.
    Adorno, D., Papola, F., Valeri, M., Irti, T., Splendiani, G. and Casciani, G.U. Transpl.Proc. 1:23, 1984.Google Scholar
  21. 21.
    Terasaki, P.I. and McClelland, J.D. Nature 204:998–1000, 1964.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • C. C. Guida
    • 1
  • M. D’Errico
    • 1
  • F. Aucella
    • 1
  • G. Ciavarella
    • 2
  • G. C. Pompa
    • 1
  • G. Di Giorgio
    • 2
  • C. Stallone
    • 1
  1. 1.Nephrology and Dialysis DepartmentImmunohematology and Transfusion Service. “Casa Sollievo della Sofferenza” HospitalSan Giovanni Rotondo, FoggiaItaly
  2. 2.Immunohematology and Transfusion Service. “Casa Sollievo della Sofferenza” HospitalSan Giovanni Rotondo, FoggiaItaly

Personalised recommendations